Protalix BioTherapeutics, Inc.PLXNYSE
LOADING
|||
Cash Generation Expanding
Trending higher, above historical average.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$7.39M
↑ 147% above average
Average (9y)
$-15.63M
Historical baseline
Range
High:$7.39M
Low:$-32.95M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $7.39M | +399.6% |
| 2023 | $-2.47M | +90.4% |
| 2022 | $-25.63M | -118.2% |
| 2021 | $-11.74M | +56.1% |
| 2020 | $-26.76M | -33.9% |
| 2019 | $-19.98M | -137.1% |
| 2018 | $-8.43M | +23.1% |
| 2017 | $-10.96M | +66.7% |
| 2016 | $-32.95M | -33.1% |
| 2015 | $-24.75M | - |